Inventor · disambiguated record
Guozhang Xu
Also filed as: XU GUOZHANG
30 granted patents·16 pending applications·43 citations·filing 2004–2024
94Inventor score
Top patents by PatentIndex Score
46 records- 0182US10214493B2Indazole derivatives useful as glucagon receptor antagonistsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Feb 26, 2019·3 cites·13 claims
- 0282US8013153B2Substituted pyrimidine kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Sep 6, 2011·14 cites·18 claims
- 0380US10000473B2Indazole derivatives useful as glucagon receptor antagonistsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Jun 19, 2018·3 cites·20 claims
- 0476US8445690B2Aminothiazolones as estrogen related receptor-alpha modulatorsBIGNAN GILLES·Filed 2011·Granted May 21, 2013·4 cites·23 claims
- 0576US7846953B2Substituted phenoxy thiazolidinediones as estrogen related receptor-α modulatorsJANSSEN PHARMACEUTICA NV·Filed 2008·Granted Dec 7, 2010·3 cites·17 claims
- 0675US8263781B2Substituted aminothiazolone indazoles as estrogen related receptor-alpha modulatorsBIGNAN GILLES·Filed 2010·Granted Sep 11, 2012·3 cites·22 claims
- 0775US8153791B2Substituted pyrimidinyl oxime kinase inhibitorsXU GUOZHANG·Filed 2006·Granted Apr 10, 2012·5 cites·24 claims
- 0873US8796256B2Substituted thiazolidinedione indazoles, indoles and benzotriazoles as estrogen-related receptor-α modulatorsBIGNAN GILLES·Filed 2011·Granted Aug 5, 2014·3 cites·28 claims
- 0973US2024228465A1Substituted pyridine n-oxide derivatives useful as a factor xia inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2024·Application pending·0 cites
- 1070US7825244B2Intermediates useful in the synthesis of alkylquinoline and alkylquinazoline kinase modulators, and related methods of synthesisJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Nov 2, 2010·1 cites·12 claims
- 1169US11098016B2Indazole derivatives useful as glucagon receptor antagonistsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Aug 24, 2021·0 cites·12 claims
- 1267US11919881B2Substituted pyridine N-oxide derivatives useful as a factor XIa inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2022·Granted Mar 5, 2024·0 cites·9 claims
- 1367US11014917B25-fluoro-c-(aryl or heterocyclyl)-glycoside derivatives useful as dual SGLT1 / SGLT2 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted May 25, 2021·0 cites·7 claims
- 1467US8399681B2Substituted aminothiazolone indazoles as estrogen related receptor-alpha modulatorsBIGNAN GILLES·Filed 2012·Granted Mar 19, 2013·1 cites·14 claims
- 1566US8426604B2Aminothiazolones as estrogen related receptor-alpha modulatorsBIGNAN GILLES·Filed 2011·Granted Apr 23, 2013·1 cites·23 claims
- 1666US8344009B2Substituted phenoxy thiazolidinediones as estrogen related receptor-á modulatorsJANSSEN PHARMACEUTICA NV·Filed 2010·Granted Jan 1, 2013·1 cites·3 claims
- 1762US2024059704A1Cereblon Ligands and Uses ThereofUNIV MICHIGAN·Filed 2023·Application pending·0 cites
- 1862US2023295157A13-(1h-imidazol-2-yl)-2,3,8,8a-tetrahydroindolizin-5(1h)-one derivatives useful as factor xia inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 1961US12286429B25-oxo-1,2,3,5,8,8a-hexahydroindolizine-3-carboxamide derivatives useful as a factor XIa inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2022·Granted Apr 29, 2025·0 cites·13 claims
- 2061US11897880B27,8-dihydrobenzo[e]pyrido[3,4-c]azocine-2,5(3H,6H)-dione derivatives useful as a factor XIa inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2022·Granted Feb 13, 2024·0 cites·11 claims
- 2161US8748624B2Picolinamido-propanoic acid derivatives useful as glucagon receptor antagonistsCHAKRAVARTY DEVRAJ·Filed 2012·Granted Jun 10, 2014·1 cites·22 claims
- 2260US11958856B2Substituted 1,2,3,8,9,9a-hexahydro-5H-pyrrolo[1,2-a]azepin-5-ones as factor XIa inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2022·Granted Apr 16, 2024·0 cites·16 claims
- 2360US2025195484A1Cereblon ligands and uses thereofUNIV MICHIGAN·Filed 2023·Application pending·0 cites
- 2459US11845748B2Bicyclic pyridine N-oxide derivatives useful as a factor XIa inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2022·Granted Dec 19, 2023·0 cites·10 claims
- 2559US10774048B2Indazole derivatives useful as glucagon receptor antagonistsJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Sep 15, 2020·0 cites·10 claims
- 2659US10696662B25-fluoro-C-(aryl or heterocyclyl)-glycoside derivatives useful as dual SGLT1 / SGLT2 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Jun 30, 2020·0 cites·19 claims
- 2759US2023183233A1Bicyclic Pyridin-2-one and pyrimidin-4-one Derivatives Useful As a Factor XIa InhibitorsJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 2858US2023097157A1Bicyclic Pyridin-2-one and pyrimidin-4-one Derivatives Useful As a Factor XIa InhibitorsJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 2955US11814364B2Pyridine N-oxide derivatives useful as factor XIa inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2022·Granted Nov 14, 2023·0 cites·10 claims
- 3055US2022009906A1Isoindolin-1-one derivatives useful as grk2 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 3152US2021388016A1Glucopyranose derivatives useful as sglt2 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2019·Application pending·0 cites
- 3251US2022242850A1Phthalazin-1-one derivatives useful as grk2 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2020·Application pending·0 cites
- 3350US2022267298A1Quinazolin-4-one derivatives useful as grk2 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2020·Application pending·0 cites
- 3447US7893064B2Hydrazone derivatives as kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Feb 22, 2011·0 cites·22 claims
- 3547US2022220125A1Fused isoindolin-1-one derivatives useful as grk2 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2020·Application pending·0 cites
- 3645US9012412B2Dual SGLT1/SGLT2 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Apr 21, 2015·0 cites·20 claims
- 3745US2021388015A1Glucopyranose derivatives useful as sglt2 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2019·Application pending·0 cites
- 3844US7550474B2Substituted phenyl acetamides and their use as protease inhibitorsJOHNSON & JOHNSON PHARM RES·Filed 2004·Granted Jun 23, 2009·0 cites·42 claims
- 3944US2021238170A15,5-Difluoro- and 5-Fluoro-5-Methyl-C-Glycoside Derivatives Useful As Dual SGLT1 / SGLT2 ModulatorsJANSSEN PHARMACEUTICA NV·Filed 2019·Application pending·0 cites
- 4041US10815210B2Benzocyclobutane derivatives useful as dual SGLT1 / SGLT2 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Oct 27, 2020·0 cites·14 claims
- 4141US10251864B2Indole derivatives useful as glucagon receptor antagonistsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Apr 9, 2019·0 cites·14 claims
- 4240US2007021435A1Aminopyrimidines as kinase modulatorsGAUL MICHAEL D·Filed 2006·Application pending·0 cites
- 4340US2006281764A1Aminopyrimidines as kinase modulatorsGAUL MICHAEL D·Filed 2006·Application pending·0 cites
- 4436US8071768B2Alkylquinoline and alkylquinazoline kinase modulatorsBAINDUR NAND·Filed 2006·Granted Dec 6, 2011·0 cites·12 claims
- 4535US2007004763A1Aminoquinoline and aminoquinazoline kinase modulatorsBAINDUR NAND·Filed 2006·Application pending·0 cites
- 4633US9045389B2Biphenyl derivatives useful as glucagon receptor antagonistsCHAKRAVARTY DEVRAJ·Filed 2012·Granted Jun 2, 2015·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Guozhang Xu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →